"Instead of looking for scapegoats overseas, the U.S. administration has to focus on putting its house in order," a Russian analyst said.
The United States must address domestic challenges caused by COVID-19 rather than put all its efforts into looking for scapegoats to blame for its own problems, said the Russian International Affairs Council (RIAC) Director Andrey Kortunov.
RELATED:
COVID-19 Pandemic Has Worsened in the US, the Authority Says
The investigation led by the U.S. intelligence community into COVID-19 origins has a clear end-goal of diverting attention from the country's pandemic response failures and casting blame on China.
"The epic U.S. failure to cope with the pandemic, especially in comparison with the undoubtedly superior performance of China... casts a shadow on the ability of the U.S. to serve as the global model and as the global leader," Kortunov said.
Even with a huge health budget, the United States showed it was dangerously unprepared to fight the pandemic and continues to be the country with the world's most COVID-19 deaths and confirmed cases to date.
This chart shows the share of the population who has received at least one vaccine.
— Our World in Data (@OurWorldInData) August 2, 2021
Shown is the data for the world’s largest countries, for which we have data.
[All our COVID vaccination data you find here: https://t.co/cMpTPb4B41] pic.twitter.com/iI5Baedloj
"Instead of looking for scapegoats overseas, the U.S. administration has to focus on putting its house in order," the RIAC Director pointed out, adding that the pandemic has exposed fundamental flaws rooted in the U.S. health care system.
"Badmouthing China will not help in addressing these problems, while carefully studying the Chinese experience in coping with the pandemic and in managing its public health system probably will," he concluded.
Kortunov said that leadership in the 21st century should not be marked by aggressive smear campaigns but empathy and the ability to learn from best practices, which the United States has yet to demonstrate.
Despite an intensified US blockade, #Cuba provides the world with two COVID-19 vaccines.
— teleSUR English (@telesurenglish) June 22, 2021
Soberana 02, with 62% efficacy after two doses—likely to rise after the Soberana Plus trial results are known.
Abdala, with 92.28% efficacy after three doses—the third highest worldwide. pic.twitter.com/xwT7jV7mMf